FCB New York Wins Sports Emmy for Michelob ULTRA’s “McEnroe vs McEnroe”
The AI-powered tennis match that aired as a prime-time special on ESPN tops off a stunning awards season for brand and agency
NEW YORK, May 25, 2023 (GLOBE NEWSWIRE) -- FCB New York and Michelob ULTRA have been awarded the 2023 Sports Emmy for Outstanding Digital Innovation by the International Academy of Television Arts & Sciences for the groundbreaking long-form film “McEnroe vs McEnroe,” a first-of-its-kind branded AI activation that aired as a prime-time special on ESPN.
Through the combination of AI, Unreal Engine MetaHuman technology, body tracking, and a pair of perfectly synchronized robotic arms, “McEnroe vs McEnroe” became the first tennis match in history in which a legend of the sport was able to take on younger versions of himself in real time. The final result was so impressive that ESPN decided to air it — free of charge to the brand — as an hour-long special in prime time across 52 countries. With over 10 million views, “McEnroe vs McEnroe” became one of the most-watched sports events of the year, besting the 2021 NBA Finals.
This win marks the first Sports Emmy for both Michelob ULTRA and FCB New York, which, throughout their multi-year partnership, have been pushing the boundaries of technology in novel ways to enhance the enjoyment of sports. Like in 2020, when COVID-19 restrictions made it impossible for fans to attend games in person, and they launched “Courtside,” a platform that allowed fans to attend virtually — which included seeing their faces in the stands and chatting with people in their “section” — by scanning a Michelob ULTRA bottle.
Michelob ULTRA’s distinct positioning around joy — doubling down on cultural relevance, grabbing people’s attention and reminding them that joy is not just an afterthought — has helped the brand grow to the 2nd-biggest beer in the country. They’ve achieved this success despite relentless category competition and headwinds for the light-beer category, which has declined 3% to 4% per year since 2013.
To date, “McEnroe vs McEnroe” has earned more than 120 media placements, with Sports Illustrated saying it “could be the future of sports” and Yahoo! praising it for “reinventing sports entertainment.” Since the launch of the program, organic searches for “Michelob ULTRA” have grown by 95%.
“An idea as ambitious as ‘McEnroe vs McEnroe’ can only happen when you have that perfect storm of relentless creatives, visionary clients and dedicated partners — all with a Never Finished spirit and a shared belief in the power of creativity as an economic multiplier,” said Michael Aimette, Chief Creative Officer of FCB New York.
“We simply can’t thank our clients at Michelob ULTRA enough for locking arms with us to bring this idea to life, and for always proving that ‘it’s only worth it if you enjoy it,’” added Emma Armstrong, FCB New York’s CEO.
FCB New York is currently the #1 agency in the world according to the recently released One Club Global Rankings, as well as the #1 Creative Agency for Effectiveness as named in the WARC Effective 100 list. It was awarded Agency of the Year by the Clios, as well as Campaign’s Experiential and B2B Agency of the Year, and was named to the Contagious Pioneers list of best and bravest agencies in the world.
“McEnroe vs McEnroe” has swept the 2022/2023 advertising awards season, taking home Ad Age’s Tech Innovation of the Year, five Cannes Lions, 15 Clios, 13 ADC awards and 24 awards at The One Show.
FCB (Foote, Cone & Belding) is a global, award-winning and integrated marketing communications company with a heritage of creativity and success dating from 1873.
FCB New York has been recognized globally for using creativity as an economic multiplier to drive meaningful business results for its clients, among them AB InBev, the FDA, MorningStar Farms, New York Mets and Spotify. In 2023 alone, the agency was named the #1 agency in the world on The One Club’s Global Rankings, awarded Agency of the Year by the Clios, honored as WARC’s #1 Creative Agency for Effectiveness, named to Contagious Pioneers’ list of best and bravest agencies in the world, and chosen as Campaign’s Experiential and B2B Agency of the Year. With more than 8,000 people in 109 operations in 80 countries, FCB is part of the Interpublic Group of Companies (NYSE: IPG). Visit fcb.com or follow @FCBglobal and@fcbnewyork on Instagram.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/bad08191-bfbb-4459-b953-11d132d29c8aTo view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Telesis Bio Announces Closing of $28.0 Million Private Placement of Preferred Stock And Warrants to Purchase an Additional $46.2 Million of Common Stock5.6.2023 23:30:00 CEST | Press release
SAN DIEGO, June 05, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in molecular biology automation solutions for multi-omic and synthetic biology applications, today announced the closing of its private placement of redeemable convertible preferred stock and warrants resulting in initial gross proceeds of $28.0 million to Telesis Bio. The warrants issued in the private placement will provide Telesis Bio with approximately $46.2 million in additional gross proceeds if they are cash exercised. The financing was led by Novalis LifeSciences LLC with participation from Northpond Ventures, BroadOak Capital Partners and M-185 Corporation, an affiliate of the Company’s Chief Executive Officer and Founder, Todd R. Nelson, PhD. The Company also announced the appointment of Paul Meister, a partner at Novalis LifeSciences LLC, to the Company’s board of directors immediately following the closing. Please refer to the Company’s Form 8-K to be filed with the Securities and Exchang
Galapagos to showcase CAR-T point-of-care manufacturing and initial Phase 1/2 CLL data with CD19 CAR-T candidate, GLPG5201, at the EHA 2023 congress5.6.2023 22:01:00 CEST | Press release
All 7 out of 7 eligible patients with relapsed/refractory chronic lymphocytic leukemia (rrCLL), with or without Richter’s Transformation (RT), responded to treatment (Objective Response Rate of 100%)1 GLPG5201 showed no cytokine release syndrome (CRS) higher than grade 2, or immune effector cell-associated neurotoxicity syndrome (ICANS)2 A functionally closed, automated manufacturing platform for cell therapies at the point-of-care will be shown at the Galapagos booth A.103at the EHA 2023 congress Mechelen, Belgium; 5 June 2023,22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will feature theCAR-T point-of-care manufacturing platform and willpresent previously disclosed initial Phase 1/2 data with CD19 CAR-T candidate, GLPG5201, at the European Hematology Association (EHA) 2023 congress, taking place from 8 June to 11June 2023 in Frankfurt, Germany. “Patients who develop rrCLL and become resistant to new agents have a very poor prognosis and a significant high
Hoylu AB: Publicerar årsredovisning för 20225.6.2023 21:15:00 CEST | Pressemelding
Hoylu AB (publ) meddelar idag att årsredovisningen för räkenskapsåret 2022 bifogas detta pressmeddelande och finns tillgänglig på bolagets hemsida: (https://www.hoylu.com/investor-relations/financial-reports/). För mer information kontakta: Truls Baklid, CEO, +47 924 38 900 Email: firstname.lastname@example.org Karl Wiersholm, CFO, +1 425 829 2316 Email: email@example.com Om Hoylu Hoylus uppdrag är att ge distribuerade team möjlighet att samarbeta enkelt och sömlöst samtidigt som de alltid håller sig synkroniserade. Hoylus Adaptive Workspaces™ hjälper företag såväl stora som små att driva projekt, program och initiativ över olika tidszoner och kontinenter med samma engagemang och tydlighet som om alla arbetade i samma rum. För mer information: www.hoylu.com Kortnamn: Hoylu Marknadsplats: Nasdaq First North Growth Stockholm Certified Adviser: Mangold Fondkommission AB +46 (0) 8 50 301 550; firstname.lastname@example.org Publicering Informationen lämnades, genom ovanstående kontaktpersons försorg för offentliggörande den 5 ju
Hoylu AB: Publishes its Annual Report for 20225.6.2023 21:15:00 CEST | Press release
Hoylu AB (publ) announced today that the Annual Report for 2022 is attached to this press release and is available on Hoylu's web site: (https://www.hoylu.com/investor-relations/financial-reports/). For more information contact: Truls Baklid, CEO, +47 924 38 900 Email: email@example.com Karl Wiersholm, CFO, +1 425 829 2316 Email: firstname.lastname@example.org About Hoylu Hoylu’s visual collaboration technology empowers distributed teams to translate ideas into actions. Large enterprises as well as small and medium companies rely on Hoylu to run projects, programs, and initiatives across time zones and continents as seamlessly as when working in the same room. For more information: www.hoylu.com Try Hoylu for free: https://app.hoylu.com/ Ticker symbol: Hoylu Marketplace: Nasdaq First North Growth Market Certified Adviser: Mangold Fondkommission AB +46 (0) 8 50 301 550, email@example.com Publication The information was submitted for publication, through the agency of the contact person set out above, at 21:15 CE
Nokia Corporation: Repurchase of own shares on 05.06.20235.6.2023 20:00:00 CEST | Press release
Nokia Corporation Stock Exchange Release 5 June 2023 at 21:00 EEST Nokia Corporation: Repurchase of own shares on 05.06.2023 Espoo, Finland – On 5 June 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL308,5933.85CEUX48,4053.86AQEU4,7293.86TQEX3,3733.87Total365,1003.86 * Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The second phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 5 April 2022 started on 2 January 2023 and en